Previous Chapter Chapter 14: The Case of Wyeth, DesignWrite, and Premarin: The Ethics of Ghostwriting Medical Journal Articles Next Chapter

Alexander Lyon & Mark Ricci

In: Case Studies in Organizational Communication: Ethical Perspectives and Practices

Chapter 14: The Case of Wyeth, DesignWrite, and Premarin: The Ethics of Ghostwriting Medical Journal Articles

  • Citations
  • Add to My List
  • Text Size

The Case of Wyeth, DesignWrite, and Premarin: The Ethics of Ghostwriting Medical Journal Articles
The case of wyeth, designwrite, and premarin: The ethics of ghostwriting medical journal articles
AlexanderLyonand MarkRicci

This case explores the role of ghostwriters in the marketing of drugs, as pharmaceutical companies seek greater profits through the medicalization of normal parts of life. As the authors note, the practice of ghostwriting raises serious questions about the transparency and trustworthiness of the information in medical journals and, in turn, the decision making of physicians and their patients. The case considers the challenges of pharmaceutical companies to address the tension between profits and patients.

Medicine has become big business. “Big pharma” companies like Eli Lilly, Bristol-Myers Squibb, Merck, and others earn over $20 billion a year, more ...

Looks like you do not have access to this content.

Please login via your institution.

Click here for free trial login.

Back to Top